Cariporide sodium/hydrogen exchange inhibitor: AVE halted enrollment in EXPEDITION, a Phase III trial of 2-day i.v. Cariporide to treat CABG patients, on the re

Aventis SA (AVE), Strasbourg, France Product: Cariporide sodium/hydrogen exchange inhibitor Business: Cardiovascular Therapeutic category: Ion channel modulation Target: Sodium/hydrogen transporter De...